NCT04527757

Brief Summary

Intravenous anaesthesia induction is nowadays considered as gold standard, mainly because of the possibility of the rapid therapeutic intervention while having secured i.v. line. In the paediatric patients, apart from intravenous induction, it is also possible to use in the specific situations inhalation anaesthesia induction with sevoflurane (in the mixture with O2 + air, or O2 + N2O) and secure the i.v. line afterwards in the inhalation anaesthesia. This method is in the paediatric population currently preferred, mainly because of possible fear of the painful venipuncture. Inhalation anaesthesia induction is possible only in patients without the risk of aspiration/regurgitation of stomach content and in patients without predicted difficult airway. Even if sedative premedication is used, during the inhalation induction excitation stage of the general anaesthesia variably appears, during which hemodynamic sympathoadrenal response and involuntary limbs movement might occur. When deepening inhalation anaesthesia, progression to surgical stage and automatic breathing onset appears. This subsequently facilitates to secure the venous access, without which is is not possible to secure the airway (in exception of the emergency situations - resuscitation).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 27, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

March 2, 2022

Status Verified

February 1, 2022

Enrollment Period

1.4 years

First QC Date

August 21, 2020

Last Update Submit

February 28, 2022

Conditions

Keywords

AnaesthesiaPaediatricInhalationIntravenous

Outcome Measures

Primary Outcomes (1)

  • duration of anaesthesia induction

    The average duration of inhalation and intravenous anaesthesia induction will be measured, defined as the time since the beginning of monitoring of the vital functions (ECG, pulse oximetry, non-invasive blood pressure measurement) until the first ETCO2 wave.

    Intraoperatively

Secondary Outcomes (6)

  • The number of attempts needed to secure i.v. line

    Intraoperatively

  • success rate of securing the i.v. line while using EMLA patch and/or Buzzy

    Intraoperatively

  • Airway management

    Intraoperatively

  • incidence of adverse events

    Intraoperatively

  • Type of premedication

    Intraoperatively

  • +1 more secondary outcomes

Study Arms (2)

Paediatric patients with inhalation induction

The measurement will begin after the patient's arrival at the operating theatre, after the control of the documentation and beginning of the vital signs monitoring. The measurement will be terminated at the occurence of the first ETCO2 wave, after securing the airway with laryngeal mask or orotracheal intubation. For the inhalation induction sevoflurane will be used (in the mixture with O2 + air, or O2 + N2O).

Procedure: Inhalation induction

Paediatric patients with intravenous induction

The measurement will begin after the patient's arrival at the operating theatre, after the control of the documentation and beginning of the vital signs monitoring. The measurement will be terminated at the occurence of the first ETCO2 wave, after securing the airway with laryngeal mask or orotracheal intubation. For the inhalation induction sevoflurane will be used (in the mixture with O2 + air, or O2 + N2O). For the intravenous induction, commonly used induction anaesthetics will be used (propofol, etomidate, ketamine, midazolam).

Procedure: Intravenous induction

Interventions

For the inhalation induction sevoflurane will be used (in the mixture with O2 + air, or O2 + N2O).

Also known as: Anaesthesia inhalation induction
Paediatric patients with inhalation induction

For the intravenous induction, commonly used induction anaesthetics will be used (propofol, etomidate, ketamine, midazolam).

Also known as: Anaesthesia intravenous induction
Paediatric patients with intravenous induction

Eligibility Criteria

Age28 Days - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients scheduled for elective surgical or diagnostic procedure in the term from 10.9.2020 until 30.6.2021.

You may qualify if:

  • paediatric patients scheduled for elective surgical or diagnostic procedure in the term from 10.9.2020 until 30.6.2021.

You may not qualify if:

  • Patients in the age from 0 to 1 month
  • patients with predicted difficult airway
  • emergency/urgent surgeries
  • patients at the risk of regurgitation/aspiration of the stomach content
  • procedures in which the airway will not be secured with laryngeal mask or orotracheal intubation
  • cases were the time of induction can not be measured
  • patients with intravenous line in situ

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Brno

Brno, 62500, Czechia

Location

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Petr Štourač, prof. MD., Ph.D.

    Faculty of medicince Masaryk University and University Hospital Brno

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof.MD,Ph.D.

Study Record Dates

First Submitted

August 21, 2020

First Posted

August 27, 2020

Study Start

October 1, 2020

Primary Completion

February 28, 2022

Study Completion

February 28, 2022

Last Updated

March 2, 2022

Record last verified: 2022-02

Locations